Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression.
about
Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South AfricaShifting the paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection.Identifying individuals with virologic failure after initiating effective antiretroviral therapy: The surprising value of mean corpuscular hemoglobin in a cross-sectional studySecond-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcomePharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring.Impact of a clinical program using weekly Short Message Service (SMS) on antiretroviral therapy adherence support in South Africa: a retrospective cohort study.Patient communication tools to enhance ART adherence counseling in low and high resource settings.Factors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trialViral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switchThe Association of HIV-Related Stigma to HIV Medication Adherence: A Systematic Review and Synthesis of the Literature.Odds of Viral Suppression by Single-Tablet Regimens, Multiple-Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy.A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.Increased Antiretroviral Therapy Use and Virologic Suppression in the Bronx in the Context of Multiple HIV Prevention Strategies.Mean corpuscular volume (MCV) values reflect therapeutic effectiveness in zidovudine-receiving HIV patients.Measurement issues in using pharmacy records to calculate adherence to antiretroviral drugs.British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
P2860
Q28477379-DBDB820D-AC23-426C-91DE-45F686025A22Q30666487-5FA57434-A0A1-43E5-8306-169FEC47AFB5Q34067651-114BD610-69FF-49E6-8719-3F6F24D668B4Q34292437-42EDE1E0-AB7F-4692-A411-A79C636719AFQ34699180-84E032CA-8F72-4E32-9D8D-08AEC7349AC2Q36285679-D3EC760F-3209-420E-A59F-FF5C0BF89EF5Q36291345-EB258918-96D9-4D56-BB3B-55825321A50AQ36882476-1C2A8679-90E5-4ACA-B47E-38D2D6E9761CQ37582314-145D48BC-9EA5-4E84-BE73-A512681EE212Q38572844-5078C70E-35D4-40F8-A63C-733A2D330462Q39060951-6E828A3F-CBBB-4C14-B6D2-8982AC78EAC1Q40724324-9EBDAC45-AB36-402B-9414-2C16683BF3E7Q40785784-CAF71355-3FDC-46CB-801C-2AFB88B75072Q42269389-270F9F72-007D-4B2B-A467-A26CCB4673BCQ45309105-AB0F1266-6B04-4FC9-9F86-54D92CF3291DQ57180790-3114384A-37D4-4588-80FD-D008126BC2AD
P2860
Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Use of a prescription-based me ...... iduals with viral suppression.
@en
Use of a prescription-based me ...... iduals with viral suppression.
@nl
type
label
Use of a prescription-based me ...... iduals with viral suppression.
@en
Use of a prescription-based me ...... iduals with viral suppression.
@nl
prefLabel
Use of a prescription-based me ...... iduals with viral suppression.
@en
Use of a prescription-based me ...... iduals with viral suppression.
@nl
P2093
P1433
P1476
Use of a prescription-based me ...... iduals with viral suppression.
@en
P2093
A J Rodger
A M Geretti
A N Phillips
J Holloway
V Cambiano
P304
P356
10.1111/J.1468-1293.2009.00771.X
P577
2009-12-03T00:00:00Z